As of May, 2021; 40% of the COVID-19 vaccines administered globally have gone to people in 27 wealth nations that represent only 11% of the global population. Amidst this vaccine inequality in the backdrop of the pandemic in the world, every country should have the right to make its own vaccine. That's the principle, underpinning the campaign to temporarily waive Intellectual Property (IP) protection on coronavirus vaccines. (a) Suppose the IP is waived (the know-how is available to everyone) and Bangladesh can make its own vaccine. Using the theories of demand-supply and market, discuss the impact of this scenario on the price, quantity, profit margins of the vaccine producing firms, consumers' surplus, producers' surplus in the COVID-19 vaccine market of Bangladesh. (b) Suppose the Government of Bangladesh imposes a per-unit tax on the vaccines sold by "B". Who will bear most of this tax burden and why? (c) If the IP is not waived and only one company "B" is approved for producing the vaccine in Bangladesh, how will it affect the price, quantity, and social welfare in the vaccine market?
As of May, 2021; 40% of the COVID-19 vaccines administered globally have gone to people in 27 wealth nations that represent only 11% of the global population. Amidst this vaccine inequality in the backdrop of the pandemic in the world, every country should have the right to make its own vaccine. That's the principle, underpinning the campaign to temporarily waive Intellectual Property (IP) protection on coronavirus vaccines. (a) Suppose the IP is waived (the know-how is available to everyone) and Bangladesh can make its own vaccine. Using the theories of demand-supply and market, discuss the impact of this scenario on the price, quantity, profit margins of the vaccine producing firms, consumers' surplus, producers' surplus in the COVID-19 vaccine market of Bangladesh. (b) Suppose the Government of Bangladesh imposes a per-unit tax on the vaccines sold by "B". Who will bear most of this tax burden and why? (c) If the IP is not waived and only one company "B" is approved for producing the vaccine in Bangladesh, how will it affect the price, quantity, and social welfare in the vaccine market?
Chapter1: Making Economics Decisions
Section: Chapter Questions
Problem 1QTC
Related questions
Question
![As of May, 2021; 40% of the COVID-19 vaccines administered globally have gone to people in
27 wealth nations that represent only 11% of the global population. Amidst this vaccine inequality
in the backdrop of the pandemic in the world, every country should have the right to make its own
vaccine. That's the principle, underpinning the campaign to temporarily waive Intellectual
Property (IP) protection on coronavirus vaccines.
(a) Suppose the IP is waived (the know-how is available to everyone) and Bangladesh can make
its own vaccine. Using the theories of demand-supply and market, discuss the impact of this
scenario on the price, quantity, profit margins of the vaccine producing firms, consumers' surplus,
producers' surplus in the COVID-19 vaccine market of Bangladesh.
(b) Suppose the Government of Bangladesh imposes a per-unit tax on the vaccines sold by "B".
Who will bear most of this tax burden and why?
(c) If the IP is not waived and only one company "B" is approved for producing the vaccine in
Bangladesh, how will it affect the price, quantity, and social welfare in the vaccine market?
(d) If the company “B" is the sole producer of vaccine in Bangladesh, how can it further increase
its profit by charging different prices based on different groups of consumers?
Use microeconomic tools to analyze, frame, and explain your answer.](/v2/_next/image?url=https%3A%2F%2Fcontent.bartleby.com%2Fqna-images%2Fquestion%2Fcf6419f9-ba25-4758-8edd-5018902550da%2Fe942f0dd-be3b-4b5d-a1c3-2016ba3d0006%2Fhy8kxe1_processed.jpeg&w=3840&q=75)
Transcribed Image Text:As of May, 2021; 40% of the COVID-19 vaccines administered globally have gone to people in
27 wealth nations that represent only 11% of the global population. Amidst this vaccine inequality
in the backdrop of the pandemic in the world, every country should have the right to make its own
vaccine. That's the principle, underpinning the campaign to temporarily waive Intellectual
Property (IP) protection on coronavirus vaccines.
(a) Suppose the IP is waived (the know-how is available to everyone) and Bangladesh can make
its own vaccine. Using the theories of demand-supply and market, discuss the impact of this
scenario on the price, quantity, profit margins of the vaccine producing firms, consumers' surplus,
producers' surplus in the COVID-19 vaccine market of Bangladesh.
(b) Suppose the Government of Bangladesh imposes a per-unit tax on the vaccines sold by "B".
Who will bear most of this tax burden and why?
(c) If the IP is not waived and only one company "B" is approved for producing the vaccine in
Bangladesh, how will it affect the price, quantity, and social welfare in the vaccine market?
(d) If the company “B" is the sole producer of vaccine in Bangladesh, how can it further increase
its profit by charging different prices based on different groups of consumers?
Use microeconomic tools to analyze, frame, and explain your answer.
Expert Solution
![](/static/compass_v2/shared-icons/check-mark.png)
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 3 steps
![Blurred answer](/static/compass_v2/solution-images/blurred-answer.jpg)
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, economics and related others by exploring similar questions and additional content below.Recommended textbooks for you
![ENGR.ECONOMIC ANALYSIS](https://compass-isbn-assets.s3.amazonaws.com/isbn_cover_images/9780190931919/9780190931919_smallCoverImage.gif)
![Principles of Economics (12th Edition)](https://www.bartleby.com/isbn_cover_images/9780134078779/9780134078779_smallCoverImage.gif)
Principles of Economics (12th Edition)
Economics
ISBN:
9780134078779
Author:
Karl E. Case, Ray C. Fair, Sharon E. Oster
Publisher:
PEARSON
![Engineering Economy (17th Edition)](https://www.bartleby.com/isbn_cover_images/9780134870069/9780134870069_smallCoverImage.gif)
Engineering Economy (17th Edition)
Economics
ISBN:
9780134870069
Author:
William G. Sullivan, Elin M. Wicks, C. Patrick Koelling
Publisher:
PEARSON
![ENGR.ECONOMIC ANALYSIS](https://compass-isbn-assets.s3.amazonaws.com/isbn_cover_images/9780190931919/9780190931919_smallCoverImage.gif)
![Principles of Economics (12th Edition)](https://www.bartleby.com/isbn_cover_images/9780134078779/9780134078779_smallCoverImage.gif)
Principles of Economics (12th Edition)
Economics
ISBN:
9780134078779
Author:
Karl E. Case, Ray C. Fair, Sharon E. Oster
Publisher:
PEARSON
![Engineering Economy (17th Edition)](https://www.bartleby.com/isbn_cover_images/9780134870069/9780134870069_smallCoverImage.gif)
Engineering Economy (17th Edition)
Economics
ISBN:
9780134870069
Author:
William G. Sullivan, Elin M. Wicks, C. Patrick Koelling
Publisher:
PEARSON
![Principles of Economics (MindTap Course List)](https://www.bartleby.com/isbn_cover_images/9781305585126/9781305585126_smallCoverImage.gif)
Principles of Economics (MindTap Course List)
Economics
ISBN:
9781305585126
Author:
N. Gregory Mankiw
Publisher:
Cengage Learning
![Managerial Economics: A Problem Solving Approach](https://www.bartleby.com/isbn_cover_images/9781337106665/9781337106665_smallCoverImage.gif)
Managerial Economics: A Problem Solving Approach
Economics
ISBN:
9781337106665
Author:
Luke M. Froeb, Brian T. McCann, Michael R. Ward, Mike Shor
Publisher:
Cengage Learning
![Managerial Economics & Business Strategy (Mcgraw-…](https://www.bartleby.com/isbn_cover_images/9781259290619/9781259290619_smallCoverImage.gif)
Managerial Economics & Business Strategy (Mcgraw-…
Economics
ISBN:
9781259290619
Author:
Michael Baye, Jeff Prince
Publisher:
McGraw-Hill Education